Related Experiment Video
Updated: Jun 15, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
HPV Self-Sampling for Cervical Cancer Screening in Under-Screened Saskatchewan Populations: A Pilot Study
Erin Vink1, Gabriella Antaya1, Camille Hamula2
1College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.
Human papillomavirus (HPV) self-sampling kits can improve cervical cancer screening. In-person distribution of these kits was more effective than mailouts, especially for high-risk populations.
Area of Science:
- Oncology
- Public Health
- Gynecology
Background:
- Cervical cancer incidence is rapidly increasing among Canadian females.
- Saskatchewan, a sparsely populated province, faces challenges in cervical cancer screening participation.
- Human papillomavirus (HPV) testing is a key strategy for cervical cancer prevention.
Purpose of the Study:
- To evaluate the effectiveness of HPV self-sampling in improving cervical cancer screening participation.
- To compare participation rates between mailed and in-person distributed self-sampling kits in urban and rural settings.
Main Methods:
- A pilot study involved 500 participants (aged 30-69) in Saskatchewan.
- Participants were randomized to receive HPV self-sampling kits via mailout (n=250) or in-person handout (n=250).
- Returned samples were analyzed for HPV strains using the Roche Cobas 4800® System.
Main Results:
- The overall response rate for HPV self-sampling was approximately 16%.
- In-person kit distribution achieved a roughly double response rate compared to mailouts.
- Higher HPV positivity was observed in an inner-city clinic group compared to other groups.
Conclusions:
- In-person distribution of HPV self-sampling kits may enhance screening participation.
- Targeted in-person outreach may be most effective for high-risk populations.
- Further research is needed to optimize HPV self-sampling strategies for cervical cancer prevention.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012